Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · IEX Real-Time Price · USD
20.69
-0.31 (-1.48%)
At close: Jul 2, 2024, 4:00 PM
20.29
-0.40 (-1.93%)
After-hours: Jul 2, 2024, 4:57 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $532.22 million as of July 2, 2024.
Market Cap
532.22M
Enterprise Value
414.89M
1-Year Change
n/a
Ranking
Category
Stock Price
$20.69
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $532.22M, an increase of 32.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 540.20M | 34.35% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| National Research | 546.79M |
| Paragon 28 | 545.82M |
| REGENXBIO | 545.26M |
| iTeos Therapeutics | 542.20M |
| Pharming Group | 542.12M |
| SIGA Technologies | 536.97M |
| Annexon | 532.34M |
| Entrada Therapeutics | 531.64M |